Skip to main content

News and Events

Stay up-to-date about
RECOVER

News and Updates

Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.

102 Results

Filters

102 Results

Filters Applied:

Changes in the body provide clues for the development of Long COVID

A research team that includes RECOVER researchers found changes in the immune systems of people with Long COVID.
Pathobiology Adult
News Release

RECOVER-NEURO enrolls first participant in trial

RECOVER-NEURO will enroll 315 people and test several different treatments for Long COVID patients who have difficulty focusing, thinking clearly, and remembering things.
Clinical Trial Adult
News Release

NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment

Initially, RECOVER will test at least four potential treatments for Long COVID, with test of seven more treatments expected in the coming months.
Clinical Trial Adult
News Release

RECOVER-VITAL enrolls first participant in trial

RECOVER-VITAL will enroll 900 people over the next six months and seek to understand whether taking Paxlovid, an antiviral drug, can improve Long COVID symptoms caused by viral persistence.
Clinical Trial Adult
News Release

R3 Seminar Recap: RECOVER in Action: Disparities and Environmental Risk Factors in PASC, EHR Insights

During the July 11th RECOVER Research Review (R3) Seminar, presenters discussed the disparities and environmental risk factors in PASC using EHR Insights. This seminar explored racial and ethnic disparities as well as community-level environmental factors in PASC among adults.

R3 Seminar Recap

R3 Seminar Recap: RECOVER in Action: Characterization of PASC Among Adults, Cohort Insights

During the June 13th RECOVER Research Review (R3) Seminar, RECOVER researchers described a symptom-based approach for defining long COVID in adults from a study published in JAMA. This presentation is based upon some early findings from the RECOVER Adult Observational Cohort study.

R3 Seminar Recap

RECOVER Research Q&A: RECOVER “First Look” Adult Cohort Study

Find answers to some of the most frequently asked questions (FAQs) about the first findings from RECOVER's research on Long COVID in adults.

Observational Adult
Q&A

Large study provides scientists with deeper insight into long COVID symptoms

RECOVER researchers have identified the 12 symptoms that are most likely to be experienced by adults with Long COVID.

Observational Adult
News Release

Media Inquiries

Are you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.

Back to Top